Abstract
2-Hydroxypropyl-β-cyclodextrin (HP-β-CyD) includes all-trans retinoic acid (RA), covering the double-bond area of RA with substituted hydroxypropyl groups on CyD ring, as proved by the nuclear Overhauser effect (NOE) between methylene protons on the hydroxypropyl groups and the proton on RA. The formation of an inclusion complex results in hydrophilicity and stability. The effect of RA/HP-β-CyD and that of RA without HP-β-CyD on wrinkle scores and skin elasticity during skin treatment were identical, and the cutaneous stimulus was reduced comparing with RA. The results indicated that the RA/HP-β-CyD complex should help to realize new approaches in skin rejuvenation therapy.
Similar content being viewed by others
References
Cohen, M.: Tretinoin: a review of preclinical toxicological studies. Drug Dev. Res. 30, 244–251 (1993)
Elbaum, D.J.: Comparison of the stability of topical isotretinoin and topical tretinoin and their efficacy in acne. J. Am. Acad. Dermatol. 19, 486–491 (1988)
Bonhomme, L., Fredj, G., Averous, S., Szekely, A.M., Ecstein, E., Trumbic, B., Meyer, P., Lang, J.M., Misset, J., Jasmin, C.: Topical treatment of epidemic Kaposi’s sarcoma with all-trans-retinoic acid [4]. Anal. Oncol. 2, 234–235 (1991)
Fisher, G.L., Voorhees, J.J.: Molecular mechanisms of retinoid actions in skin. FASEB J. 10, 1002–1013 (1996)
Kligman, A.M., Grove, G.L., Hirose, R., Leyden, J.J.: Topical tretinoin for photoaged skin. J. Am. Acad. Dermatol. 15, 836–859 (1986)
Mandy, S.H., Thorne, E.G.: A comparison of the efficacy and safety of tretinoin cream 0.025% and 0.05%. Adv. Ther. 7, 94–99 (1990)
Lewin, A.H., Whaley, M.G., Parker, S.R., Carroll, F.I., Moreland, C.G.: 12-Carboxyretinoic acids. Synthesis and structure. J. Org. Chem. 47, 1799–1807 (1982)
Brewster, M.E., Loftsson, T.: Cyclodextrins as pharmaceutical solubilizers. Adv. Drug Deliv. Rev. 59, 645–666 (2007)
Loftsson, T., Duchene, D.: Cyclodextrins and their pharmaceutical applications. Int. J. Pharm. 329, 1–11 (2007)
Davis, M.E., Brewster, M.E.: Cyclodextrin-based pharmaceutics: past, present and future. Nat. Rev. Drug Discov. 3, 1023–1035 (2004)
Uekama, K., Hirayama, F., Irie, T.: Cyclodextrin drug carrier systems. Chem. Rev. 98, 2045–2076 (1998)
Rajewski, R.A., Stella, V.J.: Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery. J. Pharm. Sci. 85, 1142–1169 (1996)
Gould, S., Scott, R.C.: 2-Hydroxypropyl-β-cyclodextrin (HP-β-CD): a toxicology review. Food Chem. Toxicol. 43, 1451–1459 (2005)
Granero, G., Garnero, C., Longhi, M.: The effect of pH and triethanolamine on sulfisoxazole complexation with hydroxypropyl-β-cyclodextrin. Eur. J. Pharm. Sci. 20, 285–293 (2003)
Yang, B., Lin, J., Chen, Y., Liu, Y.: Artemether/hydroxypropyl-β-cyclodextrin host–guest system: characterization, phase-solubility and inclusion mode. Bioorg. Med. Chem. 17, 6311–6317 (2009)
Anadolu, R.Y., Sen, T., Tarimc, N., Birol, A., Erdem, C.: Improved acid efficacy and tolerability of retinoic acid in acne vulgaris: a new topical formulation with cyclodextrin complex. JEADV 18, 416–421 (2004)
Amdidouche, D., Darrouzet, H., Duchene, D., Poelman, M.-C.: Inclusion of retinoic acid in β-cyclodextrin. Int. J. Pharm. 54, 175–179 (1989)
Montassier, P., Duchene, D., Poelman, M.-C.: Inclusion complexes of tretinoin with cyclodextrins. Int. J. Pharm. 153, 199–209 (1997)
Montassier, P., Duchene, D., Poelman, M.-C.: In vitro release study of tretinoin from tretinoin/cyclodextrin derivative complexes. J. Incl. Phenom. Macrocycl. Chem. 31, 213–218 (1998)
Zhang, Y., Liao, K., Liu, W., Ma, X.: Study on the supramolecular inclusion complex of β-cyclodextrin with retinoic acid. Ind. J. Chem. 41, 330–332 (2002)
Seo, S.J., Kim, S.H., Sasagawa, T., Choi, Y.J., Akaike, T., Cho, C.S.: Delivery of all trans-retinoic acid (RA) to hepatocyte cell line from RA/galactosyl α-cyclodextrin inclusion complex. Eur. J. Pharm. Biopharm. 58, 681–687 (2004)
Caddeo, C., Manconi, M., Valenti, D., Pini, E., Sinico, C.: Photostability and solubility improvement of β-cyclodextrin-included tretinoin. J. Incl. Phenom. Macrocycl. Chem. 59, 293–300 (2007)
Amdidouche, D., Montassier, P., Poelman, M.-C., Duchene, D.: Evaluation by laser Doppler velocimetry of the attenuation of tretinoin induced skin irritation by β-cyclodextrin complexation. Int. J. Pharm. 111, 111–116 (1994)
WinMOPAC v3.9. Fujitsu Ltd, Tokyo, Japan (2004)
Stewart, J.J.P.: MOPAC2002 v.15. Fujitsu Ltd, Tokyo, Japan (2003)
Dewar, M.J.S., Zoebisch, E.G., Healy, E.F., Stewart, J.J.P.: Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model. J. Am. Chem. Soc. 107, 3902–3909 (1985)
Task force committee for evaluation of anti-aging function: Guidelines for evolution of anti-wrinkle products. J. Jpn. Cosmet. Sci. Soc. 31, 411–431 (2007)
Holzgrabe, U., Deubner, R., Schollmayer, C., Waibel, B.: Quantitative NMR spectroscopy—applications in drug analysis. J. Pharm. Biomed. Anal. 38, 806–812 (2005)
Lindberg, B., Pitha, J.: European Patent 9,000,524, 1990 (Chem. Abstr. 114, 143910)
Szabo, T., Szejtli, J., Szente, L., Horvath, G., Peterdi, V., Szeman, J., Toth, A., Komar, P.: Hungarian Patent HU, 202889, 1988
Schneider, H.J., Hacket, F., Rudiger, V., Ikeda, H.: NMR studies of cyclodextrins and cyclodextrin complexes. Chem. Rev. 98, 1755–1785 (1998)
Duus, J.O., Gotfredsen, C.H., Bock, K.: Carbohydrate structural determination by NMR spectroscopy: modern methods and limitations. Chem. Rev. 100, 4589–4614 (2000)
Author information
Authors and Affiliations
Corresponding author
Additional information
15th International Cyclodextrin Symposium.
Rights and permissions
About this article
Cite this article
Takahashi, K., Morimoto, S., Nakamura, H. et al. Improvement of pharmaceutical potential of all-trans retinoic acid with hydroxypropyl-β-cyclodextrin. J Incl Phenom Macrocycl Chem 70, 389–396 (2011). https://doi.org/10.1007/s10847-010-9857-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10847-010-9857-6